Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;19(12):1382-1394.
doi: 10.6004/jnccn.2021.0059.

NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022

Chrysalyne D Schmults  1 , Rachel Blitzblau  2 , Sumaira Z Aasi  3 , Murad Alam  4 , James S Andersen  5 , Brian C Baumann  6 , Jeremy Bordeaux  7 , Pei-Ling Chen  8 , Robert Chin  9 , Carlo M Contreras  10 , Dominick DiMaio  11 , Jessica M Donigan  12 , Jeffrey M Farma  13 , Karthik Ghosh  14 , Roy C Grekin  15 , Kelly Harms  16 , Alan L Ho  17 , Ashley Holder  18 , John Nicholas Lukens  19 , Theresa Medina  20 , Kishwer S Nehal  17 , Paul Nghiem  21 , Soo Park  22 , Tejesh Patel  23 , Igor Puzanov  24 , Jeffrey Scott  25 , Aleksandar Sekulic  14 , Ashok R Shaha  17 , Divya Srivastava  26 , William Stebbins  27 , Valencia Thomas  28 , Yaohui G Xu  29 , Beth McCullough  30 , Mary A Dwyer  30 , Mai Q Nguyen  30
Affiliations

NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022

Chrysalyne D Schmults et al. J Natl Compr Canc Netw. 2021 Dec.

Abstract

The NCCN Guidelines for Squamous Cell Skin Cancer provide recommendations for diagnostic workup, clinical stage, and treatment options for patients with cutaneous squamous cell carcinoma. The NCCN panel meets annually to discuss updates to the guidelines based on comments from panel members and the Institutional Review, as well as submissions from within NCCN and external organizations. These NCCN Guidelines Insights focus on the introduction of a new surgical recommendation terminology (peripheral and deep en face margin assessment), as well as recent updates on topical prophylaxis, immunotherapy for regional and metastatic disease, and radiation therapy.

PubMed Disclaimer

LinkOut - more resources